Health Insurance Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
American Academy of Allergy, Asthma & Immunology
Inhaled corticosteroids and antileukotriene drugs may be best treatment for asthma
August 13th, 2006
A new study provides support for the combined therapy of inhaled corticosteroids and antileukotriene drugs in the treatment of asthma. The study, "Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate", can be found in a recent issue of the Journal of Allergy and Clinical Immunology (JACI), the peer-reviewed journal of the American Academy of Allergy, Asthma and Immunology (AAAAI). P-r Gyllfors, MD, Karolinska University Hospital, Solna, Stockholm, Sweden, and colleagues investigated whether bronchial responsiveness to leukotriene D4 (a naturally-occurring substance that is increased in many asthmatic lungs,...
Source: Health Insurance Law Weekly (2006-08-13)
|
